Abstract
Objective
To demonstrate the contrast-enhancement behavior of pancreatic carcinoma on dynamic contrast-enhanced CT (DCE-CT), and the relationship between the degree of contrast-enhancement and the vascularity (vessel density) and amount of fibrous stroma (fibrosis within the tumor) on pathological specimen.
Methods
The contrast-enhancement values were measured by producing the subtracting images for obtaining largest region of interests to reduce measurement errors and variability. Vascularity was determined by immunostaining of the tissue sections with factor 8 and the fibrous stroma was determined by picrosirius staining. Correlation of the findings of DCE-CT with pathological findings was performed in 21 patients with pancreatic carcinoma.
Results
All but one patient exhibited a gradually increasing enhancement, but there was considerably wide range in contrast-enhancement values of tumors. Examination of the overall relationship between vascularity and fibrous stroma with contrast-enhancement behavior showed that tumor with more fibrosis and higher vascularity had a higher contrast effect through all phases of dynamic study. Tumors having liver metastases tended to be less fibrotic than tumors without liver metastases.
Conclusion
The contrast-enhancement behavior of pancreatic carcinoma may be helpful in estimating vascularity and the extent of tumor fibrosis and possibility of liver metastases.
Similar content being viewed by others
References
Lu DS, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 199:697–701
Freeny PC, Marks WN, Ryan JA, et al. (1988) Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 166:125–133
Megibow AJ (1992) Pancreatic adenocarccinoma: designing the examination to evaluate the clinical questions. Radiology 183:297–303
Bluemeke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385
Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology 43:1230–1237
Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985
Yasumura K, Ogawa K, Yuasa Y, et al. (2000) Dynamic MRI and tumor angiogenesis of breast cancer. Nippon Igaku Hoshasen Gakkai Zasshi 60:379–388
Buadu LD, Murakami J, Murayama S, et al. (1996) Breast lesion: correlation of contrast medium enhancement patterns on MR images with histo-pathologic findings and tumor angiogenesis. Radiology 200:639–649
Stomper PC, Winston JS, Herman S, et al. (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45:39–46
Buckley DL, Drew PJ, Mussurakis S, et al. (1997) Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced. MRI JMRI 7:461–464
Kikuchi Y, Yamauti H, Kakisaki K (1997) Liver metastasis from ductal cell adenocarcinoma of the pancreas—morphometric estimation of the stromal fraction in the cancer tissue resected and cytofluorometric analysis. J Jpn Pancreas Soc 12:273–284
Seo Y, Baba H, Fukuda T, et al. (2000) High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 88:2239–2245
Johnson PT, Outwater EK (1999) Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 212:213–218
Gabata T, Matsui O, Kadoya M, et al. (1994) Small pancreatic Adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology 193:683–688
Semelka RC, Ascher SM (1993) MR imaging of pancreas. Radiology 188:593–602
Fujioka S, Yoshida K, Yanagisawa S, et al. (2001) Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 92:1788–1797
Khan AW, Dhillon AP, Hutchins R, et al. (2002) Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur J Surg Oncol 28:637–644
Niedergethmann M, Hildenbrand R, Wostbrock B, et al. (2002) High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 25:122–129
Karademir S, Sokmen S, Terzi C, et al. (2000) Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg 7:489–495
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hata, H., Mori, H., Matsumoto, S. et al. Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging 35, 172–180 (2010). https://doi.org/10.1007/s00261-008-9460-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-008-9460-0